Search results for "R2"

showing 10 items of 285 documents

Recomendación para la determinación de HER2 en cáncer de mama. Consenso nacional de la Sociedad Española de Anatomía Patológica (SEAP) y de la Socied…

2009

La identificación de los carcinomas de mama con amplificación/sobreexpresión de HER2 es crítica en la práctica clínica diaria ya que estas neoplasias requieren un tratamiento específico que incluye el uso de terapias dirigidas. Tanto las técnicas de hibridación in situ como las técnicas inmunohistoquímicas son métodos apropiados para la identificación de cánceres de mama HER2 positivos. Sin embargo, numerosos estudios, incluidos los desarrollados por la Asociación para la Garantía de Calidad en Patología de la SEAP (AGCP) y la experiencia de centros de referencia nacionales en la determinación de HER2 han puesto de manifiesto importantes problemas de reproducibilidad entre laboratorios. Por…

Quality assessmentPhilosophy:CIENCIAS MÉDICAS [UNESCO]Pathology and Forensic MedicineCáncer de mamaCáncer de mama ; HER2 ; Inmunohistoquímica ; Hibridación in situ ; Estandarización ; Control de calidadControl de calidadUNESCO::CIENCIAS MÉDICAS ::Patología::OncologíaHER2UNESCO::CIENCIAS MÉDICASEstandarizaciónHibridación in situ:CIENCIAS MÉDICAS ::Patología::Oncología [UNESCO]HumanitiesInmunohistoquímicaRevista Española de Patología
researchProduct

Vizuāli semantiski vaicājumi pār relāciju datubāzēm

2020

Korektu vaicājumu izveide ir svarīgākais posms datu izguves procesā. Konstruējot vaicājumu vizuāli, tiek sniegta iespēja iegūt korektus datus ne tikai jomas speciālistiem, bet arī citu profesiju pārstāvjiem bez specifiskām tekstuālās vaicājuma valodas sintakses zināšanām. Dažādas vaicājumu bāzētas valodas kā SPARQL tiek izmantotas, lai iegūtu datus no semantiskā tīmekļa, bet, izmantojot minēto vaicājumu valodu, nav iespējams tieši izgūt datus no relāciju datubāzēm. Ontoloģijā bāzēta datu piekļuve ir kļuvusi par populāru pieeju lielo datu laikmetā. Darbā tiek apskatīta iespēja OBDA pieejas ietvaros veikt vizuāli semantisku vaicājumu izpildi, pār relāciju datubāzēm izmantojot R2RML. Izmantojo…

R2RMLVizuāli semantiski vaicājumiDatorzinātneOntoloģijā bāzēta datu piekļuveRelāciju datubāzesSPARQL
researchProduct

An experimental study of a refrigerating plant when replacing R22 with HFCs refrigerants

2011

This paper presents the results of an experimental analysis comparing the performance of a vapour compression refrigerating unit operating with R22, and its performance in comparison to some HFCs fluids, substituting the former according to reg. n. 2037/2000. In particular, the plant working efficiency was first tested with R22 and then with three HFC fluids: R417A, R407C and R404A. The investigation verified that the performance with HFCs refrigerants did not result as efficient as when using R22. An environmental analysis also was performed.

R407C R404A.Settore ING-IND/10 - Fisica Tecnica IndustrialeR417AR22
researchProduct

Use of HFC fluids as suitable replacements in low-temperature refrigeration plants

2014

An experimental investigation of the performance of a low-temperature refrigerating unit working with R22 and a comparison of its performance when operating with replacement HFC fluids in accordance with the European Regulation CE-1005/2009 are presented in this paper. Plant working efficiency was tested with R22, as baseline, and then compared with four different HFC fluids: R413A, R417A, R422A and R422D. The refrigerating unit was a vapour-compression plant equipped with a reciprocating double-cylinder compressor able to keep the cold room at -20ºC. Lower values of the temperature at the end of compression and polytrophic exponent can be achieved with the HFC tested. Substituting the R22 …

R422dSettore ING-IND/10 - Fisica Tecnica IndustrialeRefrigerating systemR417aR422aR22R413a
researchProduct

EBV-Induced Gene 3 Transcription Is Induced by TLR Signaling in Primary Dendritic Cells via NF-κB Activation

2005

Abstract The EBV-induced gene 3 (EBI3) is expressed in dendritic cells (DCs) and part of the cytokine IL-27 that controls Th cell development. However, its regulated expression in DCs is poorly understood. In the present study we demonstrate that EBI3 is expressed in splenic CD8−, CD8+, and plasmacytoid DC subsets and is induced upon TLR signaling. Cloning and functional analysis of the EBI3 promoter using in vivo footprinting and mutagenesis showed that stimulation via TLR2, TLR4, and TLR9 transactivated the promoter in primary DCs via NF-κB and Ets binding sites at −90 and −73 bp upstream of the transcriptional start site, respectively. Furthermore, we observed that NF-κB p50/p65 and PU.1…

RNA Capsmedicine.medical_treatmentDNA Mutational AnalysisMolecular Sequence DataImmunologyAntigen-Presenting CellsReceptors Cell SurfaceBiologyCell LineMinor Histocompatibility AntigensJurkat CellsMiceCell Line TumorGene expressionmedicineAnimalsHumansImmunology and AllergyReceptors CytokinePromoter Regions GeneticGlycoproteinsMice KnockoutMembrane GlycoproteinsInnate immune systemBase SequenceToll-Like ReceptorsHEK 293 cellsNF-kappa BTLR9hemic and immune systemsEBI3Dendritic CellsMolecular biologyToll-Like Receptor 2Up-RegulationMice Inbred C57BLToll-Like Receptor 4Protein SubunitsTLR2CytokineGene Expression RegulationToll-Like Receptor 9NIH 3T3 CellsTLR4Protein BindingSignal TransductionThe Journal of Immunology
researchProduct

Targeted Therapy Modulates the Secretome of Cancer-Associated Fibroblasts to Induce Resistance in HER2-Positive Breast Cancer

2021

The combination of trastuzumab plus pertuzumab plus docetaxel as a first-line therapy in patients with HER2-positive metastatic breast cancer has provided significant clinical benefits compared to trastuzumab plus docetaxel alone. However, despite the therapeutic success of existing therapies targeting HER2, tumours invariably relapse. Therefore, there is an urgent need to improve our understanding of the mechanisms governing resistance, so that specific therapeutic strategies can be developed to provide improved efficacy. It is well known that the tumour microenvironment (TME) has a significant impact on cancer behaviour. Cancer-associated fibroblasts (CAFs) are essential components of the…

Receptor ErbB-2Cancer-associated fibroblastQH301-705.5breast cancer; HER2-positive; tumour microenvironment; targeted therapy; trastuzumab; resistance; cancer-associated fibroblast; label-free proteomics; miRNABreast NeoplasmsDocetaxelAntibodies Monoclonal HumanizedArticleCatalysisInorganic ChemistryresistanceDrug Delivery SystemsLabel-free proteomicsbreast cancerCancer-Associated FibroblastsCell Line TumorAntineoplastic Combined Chemotherapy ProtocolsHumansPhysical and Theoretical ChemistryBiology (General)skin and connective tissue diseasesMolecular BiologyQD1-999SpectroscopymiRNAOrganic ChemistryGeneral Medicinetargeted therapyHER2-positiveComputer Science ApplicationstrastuzumabChemistryDrug Resistance NeoplasmFemaletumour microenvironmentInternational Journal of Molecular Sciences
researchProduct

Second-generation Langerhans cells originating from epidermal precursors are essential for CD8+ T cell priming.

2014

Abstract In vivo studies questioned the ability of Langerhans cells (LCs) to mediate CD8+ T cell priming. To address this issue, we used intradermal immunization with plasmid DNA, a system in which activation of CD8+ T cells depends on delayed kinetics of Ag presentation. We found that dendritic cells (DCs) located in the skin at the time of immunization have limited ability to activate CD8+ T cells. This activity was mediated by a second generation of DCs that differentiated in the skin several days after immunization, as well as by lymph node–resident DCs. Intriguingly, CD8+ T cell responses were not affected following treatment with clodronate liposomes, immunization of CCR2−/− mice, or …

Receptors CCR2T cellImmunologyPriming (immunology)CD11cchemical and pharmacologic phenomenaBiologyCD8-Positive T-LymphocytesLymphocyte ActivationMiceImmune systemGiant Cells LanghansmedicineImmunology and AllergyCytotoxic T cellAnimalsSkinMice KnockoutChemokine CCL20integumentary systemhemic and immune systemsCell DifferentiationDendritic CellsMolecular biologyCD11c AntigenCCL20Mice Inbred C57BLmedicine.anatomical_structureImmunologyIntercellular Signaling Peptides and ProteinsClodronic AcidCD8Ex vivoHeparin-binding EGF-like Growth FactorPlasmidsJournal of immunology (Baltimore, Md. : 1950)
researchProduct

Locally nilpotent derivations of rings graded by an abelian group

2019

International audience

Russel cubic threefoldPure mathematicsAffine algebraic geometryPham-Brieskorn variety010102 general mathematics[MATH.MATH-AG] Mathematics [math]/Algebraic Geometry [math.AG]Locally nilpotent13A50Locally nilpotent derivation01 natural sciences[ MATH.MATH-AG ] Mathematics [math]/Algebraic Geometry [math.AG]Russell cubic threefold0103 physical sciences010307 mathematical physics[MATH.MATH-AG]Mathematics [math]/Algebraic Geometry [math.AG]0101 mathematicsAbelian group14R20MSC: Primary 14R20 ; Secondary 13A50ComputingMilieux_MISCELLANEOUSMathematics
researchProduct

miR-20b modulates VEGF expression by targeting HIF-1 alpha and STAT3 in MCF-7 breast cancer cells.

2010

MicroRNAs (miRNAs) are small non-coding RNAs that regulate the expression of different genes, including genes involved in cancer progression. A functional link between hypoxia, a key feature of the tumor microenvironment, and miRNA expression has been documented. We investigated whether and how miR-20b can regulate the expression of vascular endothelial growth factor (VEGF) in MCF-7 breast cancer cells under normoxic and hypoxia-mimicking conditions (CoCl(2) exposure). Using immunoblotting, ELISA, and quantitative real-time PCR, we demonstrated that miR-20b decreased VEGF protein levels at 4 and 24 h following CoCl(2) treatment, and VEGF mRNA at 4 h of treatment. In addition, miR-20b reduce…

STAT3 Transcription FactorVascular Endothelial Growth Factor ATime FactorsPhysiologySettore MED/06 - Oncologia MedicaClinical BiochemistryDown-RegulationBreast NeoplasmsBiologyTransfectionchemistry.chemical_compoundmir20b VEGFCell Line TumormicroRNAHumansSTAT3Promoter Regions GeneticG alpha subunitRegulation of gene expressionTumor microenvironmentBinding SitesCell BiologyTransfectionCobaltHypoxia-Inducible Factor 1 alpha SubunitMolecular biologyCell HypoxiaVascular endothelial growth factorGene Expression Regulation NeoplasticMicroRNAsHIF1Achemistrybiology.proteinFemaleRNA InterferenceSignal TransductionJournal of cellular physiology
researchProduct

Rtp1p Is a Karyopherin-Like Protein Required for RNA Polymerase II Biogenesis

2013

The assembly and nuclear transport of RNA polymerase II (RNA pol II) are processes that require the participation of many auxiliary factors. In a yeast genetic screen, we identified a previously uncharacterized gene, YMR185w (renamed RTP1), which encodes a protein required for the nuclear import of RNA pol II. Using protein affinity purification coupled to mass spectrometry, we identified interactions between Rtp1p and members of the R2TP complex. Rtp1p also interacts, to a different extent, with several RNA pol II subunits. The pattern of interactions is compatible with a role for Rtp1p as an assembly factor that participates in the formation of the Rpb2/Rpb3 subassembly complex and its bi…

Saccharomyces cerevisiae ProteinsActive Transport Cell NucleusRNA polymerase IISaccharomyces cerevisiaeKaryopherinsBiologyGene Expression Regulation FungalTranscriptional regulationRNA polymerase IProtein Interaction MapsMolecular BiologyRNA polymerase II holoenzymeR2TP complexGeneticsNuclear cap-binding protein complexArticlesCell BiologyPhosphoproteinsUp-RegulationCell biologyNuclear Pore Complex Proteinsbiology.proteinRNA Polymerase IITranscription factor II DCarrier ProteinsGene DeletionSmall nuclear RNATranscription Factors
researchProduct